European Medical Journal news story
CAR-T clinical trials for non-Hodgkin lymphoma remain less accessible to people living with HIV, according to a new cross-sectional study that identified significant disparities in travel times and geographic access compared with the wider population.
Researchers analysed interventional CAR-T clinical trials for non-Hodgkin lymphoma listed on ClinicalTrials.gov that were actively recruiting adult participants in the contiguous United States as of May 2025. Of 254 eligible studies reviewed, 80 met inclusion criteria.
Among these 80 trials, only 11 (13.8%) explicitly included people living with HIV, while 58 (72.5%) excluded them and 11 (13.8%) did not mention HIV status in eligibility criteria. The study evaluated access by calculating population weighted travel times to the nearest trial site using geographical data from participating centres.
Read the full news story here.
Source : European Medical Journal
Related HIV and Co-Infections News
-
Northwestern University: Flu drugs show promise against cognitive decline, aging-related diseases
-
[Call to action] HIV prevention advocates applaud South Africa’s introduction of lenacapavir for PrEP
-
[BHIVA/BASHH 2026] aidsmap: Injectable PrEP in Leeds and London: criteria, approval and continuation
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.